Human Genome Epidemiology Literature Finder
|
Records 1 - 14 (of 14 Records) |
| Query Trace: Psychiatry and CYP2C19[original query] |
|---|
| [Individualized pharmacotherapy based on cytochrome P-450 (CYP) genotyping]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 2003 1 122 (29): 2781-3. Johansen Per Wiik, Bergan Stein, Rootwelt Helge, Kvittingen Eli Anne, Rugstad Hans Er |
| Role of CYP2C19 gene polymorphism in acute alcohol withdrawal treatment with loading dose of diazepam in a South Indian population. European journal of clinical pharmacology 2016 Apr . Jose Manu, Mathaiyan Jayanthi, Kattimani Shivanand, Adithan Surendiran, Chandrasekaran Adith |
| Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients. International journal of clinical pharmacy 2016 Jan . Yuce-Artun Nazan, Baskak Bora, Ozel-Kizil Erguvan Tugba, Ozdemir Hatice, Uckun Zuhal, Devrimci-Ozguven Halise, Suzen Halit Sin |
| Should a routine genotyping of CYP2D6 and CYP2C19 genetic polymorphisms be recommended to predict venlafaxine efficacy in depressed patients treated in psychiatric settings? Pharmacogenomics 2017 May . Taranu Adela, Colle Romain, Gressier Florence, El Asmar Khalil, Becquemont Laurent, Corruble Emmanuelle, Verstuyft Céli |
| Characterization CYP1A2, CYP2C9, CYP2C19 and CYP2D6 Polymorphisms Using HRMA in Psychiatry Patients with Schizophrenia and Bipolar Disease for Personalized Medicine. Combinatorial chemistry & high throughput screening 2018 6 21 (5): 374-380. Yenilmez Ebru Dundar, Tamam Lut, Karaytug Onur, Tuli Abdull |
| CYP2C19 polymorphism in relation to the pharmacotherapy optimization of commonly used drugs. Die Pharmazie 2018 11 73 (11): 619-624. Sienkiewicz-Oleszkiewicz B, Wiela-Hoje?ska |
| Use of Pharmacogenetic Drugs by the Dutch Population. Frontiers in genetics 2019 7 10 567. Alshabeeb Mohammad A, Deneer Vera H M, Khan Amjad, Asselbergs Folkert |
| High levels of several antipsychotics and antidepressants due to a pharmacogenetic cause: a case report. Pharmacogenomics 2019 6 20 (8): 567-570. Mian Paola, Somers Metten, Berg Maarten Ten, Cahn Winnie, Wilting Ingeborg, Schaik Ron v |
| Biochip-based approach for comprehensive pharmacogenetic testing. Drug metabolism and personalized therapy 2020 Dec . Ikonnikova Anna Yu, Filippova Marina A, Surzhikov Sergey A, Pozhitnova Victoria O, Kazakov Ruslan E, Lisitsa Tatiana S, Belkov Sergey A, Nasedkina Tatiana |
| CYP2C19 and CYP2D6 Genotypes and Metabolizer Status Distribution in a Bulgarian Psychiatric Cohort. Journal of personalized medicine 2022 Jul 12 (7): . Ivanov Hristo Y, Grigorova Denitsa, Lauschke Volker M, Velinov Branimir, Stoychev Kaloyan, Kyosovska Gergana, Shopov Pet |
| Clinical Impact of Functional CYP2C19 and CYP2D6 Gene Variants on Treatment with Antidepressants in Young People with Depression: A Danish Cohort Study. Pharmaceuticals (Basel, Switzerland) 2022 7 15 (7): . Thiele Liv S, Ishtiak-Ahmed Kazi, Thirstrup Janne P, Agerbo Esben, Lunenburg Carin A T C, Müller Daniel J, Gasse Christia |
| [Farmacogenetica in de psychiatrie; de huidige status quo]. Tijdschrift voor psychiatrie 2022 6 64 (5): 312-316. van Westrhenen R, Birkenhäger T |
| [Association of SCN2A, ABCB1 and CYP2C19*3 with genetic susceptibility to major depressive disorder]. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 2022 4 56 (3): 287-294. Zhang T, Rao Q M, He Y Y, Cai J T, Liu H Y, Lin Y |
| Potential Impact of Pharmacogenomic Single Nucleotide Variants in a Rural Caucasian Population. The journal of applied laboratory medicine 2023 1 8 (2): 251-263. Williams Grace R, Tsongalis Gregory J, Lewis Lionel D, Barney Rachael E, Cook Leanne J, Aaron Geno K, Nerenz Robert |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: